JSPR earnings: next report 2026-08-12, real EPS beat/miss history, analyst consensus Buy, P/E -0.22. Updated 2026-07-23.
Jasper Therapeutics (JSPR) Research Hub
Jasper Therapeutics (JSPR) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 0.6603 USD (-5.81%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.22, market cap 0.01B. This hub links to the full technical, earnings and options research available for JSPR.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.6603 USD (-5.81%) |
| 52-week range | 0.34 USD – 0.97 USD |
| Trend regime | Range |
| 14-day RSI | 44.8 (Bearish) |
| Trailing P/E | -0.22 |
| Market cap | 0.01B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-12 |
Available research for JSPR
Covered Call on JSPR: how it works, illustrative setup around the real 0.6603 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on JSPR: how it works, illustrative setup around the real 0.6603 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on JSPR: how it works, illustrative setup around the real 0.6603 USD price, max profit/loss, breakeven and when to use it. Educational.
JSPR technical analysis: range, last 0.6603 USD, RSI 44.8, 52w range 0.34 USD–0.97 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is JSPR in?
Jasper Therapeutics (JSPR) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is JSPR in an uptrend or downtrend?
As of 2026-09-11, JSPR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is JSPR's trailing P/E ratio?
JSPR's trailing P/E is -0.22, with a market cap of 0.01B. See the earnings research page for full valuation detail.
When does JSPR next report earnings?
JSPR is next scheduled to report earnings on 2026-08-12, with a consensus EPS estimate of -0.38 USD.